ZURA BIO LIMITED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.38 USD | -9.38% |
|
-10.34% | -27.62% |
| 06-14 | Zura Bio Presents Data for the Tibulizumab (Zb-106) Program At Eular 2024 | CI |
| 06-06 | Zura Bio Limited Announces Formation of a Scientific Advisory Board | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 213M | - | - | - | - | - | |
| 121B | ||||||
| 114B | ||||||
| 20.43B | - | |||||
| 16.55B | ||||||
| 16.45B | - |
- Stock Market
- Equities
- ZURA Stock
- Charts Zura Bio Limited
- Sector Chart
